Monsanto the disposition of product lines unrelated to agriculture. In 1985, Monsanto acquired G. D. Searle & Company, a life sciences company that focused on pharmaceuticals, agriculture and animal health. In 1993, its Searle division filed a patent application for Celebrex, which in 1998 became the first selective COX‑2 inhibitor to be approved by the U.S. Food and Drug Administration (FDA). Celebrex became a blockbuster drug and was often mentioned as a key reason for Pfizer's acquisition of Monsanto's pharmaceutical business in 2002. In 1994, Monsanto introduced a recombinant version of bovine somatotropin, brand-named Posilac. Monsanto later sold this business to
Circuito de Monsanto Circuito de Monsanto The Circuito de Monsanto, or Monsanto Park Circuit, was a 5.440 km (3.380-mi) race track in Monsanto Forest Park, near Lisbon, Portugal which hosted the Portuguese Grand Prix. Built on parklands, the circuit was considered difficult to drive because it crossed so many different types of surfaces, including tramlines at one point. The track hosted numerous races from 1954 to 1959, but only one race qualified as a Formula One event: the 1959 Portuguese Grand Prix, won by Stirling Moss. He won the race in the twilight hours, since the race was purposely started late in the